...
首页> 外文期刊>Cureus. >Induced Hypotension in Functional Endoscopic Sinus Surgery: A Comparative Study of Dexmedetomidine and Esmolol
【24h】

Induced Hypotension in Functional Endoscopic Sinus Surgery: A Comparative Study of Dexmedetomidine and Esmolol

机译:功能内镜鼻窦外科诱导的低血压:Dexmedetomidine和Esmolol的比较研究

获取原文

摘要

Introduction Functional endoscopic sinus surgery (FESS) is one of the common surgical procedures requiring hypotensive anesthesia; many agents have been tried to reduce the amount of blood loss. This study aims at comparing the efficacy of two agents for providing deliberate hypotension. Objectives The aim of this study was to evaluate the efficacy of esmolol and of dexmedetomidine and compare which one of the two is a better agent to produce induced hypotension during FESS. Materials and methods This was a comparative study conducted in a tertiary care hospital in Odisha, India. There were two study groups with 30 participants each who were given either esmolol or dexmedetomidine (group E and group DEX, respectively). Results Esmolol is an anti-hypertensive agent with better hemodynamic stability. The amount of drug and dose requirement was low in group DEX. The emergence time, sedation score, and time to first analgesic request were found to be highly statistically significant in group DEX. Conclusion Dexmedetomidine was found to be a better agent at controlling intra-operative blood pressure than esmolol and had beneficial effects on recovery from anesthesia and analgesia.
机译:引言功能内窥镜鼻窦外科(FESS)是需要低血压性麻醉的常见手术手术之一;已经试图减少失血量的许多药剂。本研究旨在比较两种药剂的疗效来提供故意低血压。目的这项研究的目的是评估Esmolol和Dexmedetomidine的疗效,并比较两者中的哪一个是在友邦期间产生诱导的低血压的更好药剂。材料和方法这是印度奥迪沙的第三级护理医院进行的比较研究。有两种研究组,其中30名参与者,每个参与者分别给予Esmolol或Dexmedetomidine(分别组和e和Group Dex)。结果Esmolol是一种具有更好血液动力学稳定性的抗高血压剂。药物和剂量要求的组含量低。在德克斯群体中发现出现时间,镇静评分和前一种镇痛请求的时间是高度统计学意义。结论Dexmedetomidine被发现是在控制术中血压的更好的药剂,而不是Esmolol,对麻醉和镇痛的恢复有益。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号